 Erytech Pharma SA NASDAQ: ERYP is surging higher Friday morning after the company announced its eryaspase was granted U.S. FDA Fast Track designation. The Fast Track designation is for the treatment of acute lymphocytic leukemia ALL patients who have developed hypersensitivity reactions to E. 